Galderma Group AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	22,290	23,909	-	-	-
Enterprise Value	24,376	26,211	-	-	-
Last Close Price	93.89	100.64	-	-	-
PE Ratio	106.82	114.22	-	-	-
Forward PE	40.44	43.27	-	-	-
PS Ratio	5.54	5.94	-	-	-
PB Ratio	3.16	3.39	-	-	-
P/FCF Ratio	68.33	73.29	-	-	-
P/OCF Ratio	54.07	54.07	-	-	-
PEG Ratio	1.24	1.02	-	-	-
EV/Sales Ratio	6.06	6.52	-	-	-
EV/EBITDA Ratio	29.24	32.46	-	-	-
EV/EBIT Ratio	40.09	43.11	-	-	-
EV/FCF Ratio	74.72	80.35	-	-	-
Debt / Equity Ratio	0.35	0.35	0.91	1.27	1.25
Debt / EBITDA Ratio	3.00	3.00	5.83	8.68	9.67
Debt / FCF Ratio	7.66	7.66	111.57	583.27	39.02
Asset Turnover	0.35	0.35	0.33	0.31	-
Inventory Turnover	3.29	3.29	2.86	3.03	-
Quick Ratio	0.89	0.89	0.72	0.52	0.55
Current Ratio	1.21	1.21	1.03	0.77	0.82
Return on Equity (ROE)	3.51%	3.51%	-1.16%	-2.15%	-
Return on Assets (ROA)	3.34%	3.34%	3.04%	2.01%	-
Return on Capital (ROIC)	4.03%	4.03%	3.71%	2.46%	-
Return on Capital Employed (ROCE)	6.10%	6.10%	5.60%	3.80%	3.30%
Earnings Yield	0.94%	0.88%	-	-	-
FCF Yield	1.46%	1.36%	-	-	-
Buyback Yield / Dilution	-0.10%	-0.10%	95.42%	-	-

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.